Manuel B. Graeber

Active 1988–2025

88
Papers
20,485
Citations
70
h-index
81
i10-index

Citations

Citations per year for Manuel B. Graeber1967: 1 citations1988: 15 citations1989: 32 citations1990: 64 citations1991: 81 citations1992: 95 citations1993: 129 citations1994: 72 citations1995: 84 citations1996: 74 citations1997: 63 citations1998: 150 citations1999: 146 citations2000: 159 citations2001: 205 citations2002: 173 citations2003: 193 citations2004: 203 citations2005: 174 citations2006: 162 citations2007: 156 citations2008: 195 citations2009: 196 citations2010: 188 citations2011: 263 citations2012: 247 citations2013: 243 citations2014: 250 citations2015: 232 citations2016: 194 citations2017: 237 citations2018: 162 citations2019: 471 citations2020: 494 citations2021: 482 citations2022: 369 citations2023: 453 citations2024: 742 citations2025: 395 citations2026: 8 citations1968–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,971 citing papers, 27.9% of this breakdownUnited Kingdom: 861 citing papers, 8.1% of this breakdownGermany: 838 citing papers, 7.9% of this breakdownChina: 788 citing papers, 7.4% of this breakdownItaly: 419 citing papers, 3.9% of this breakdownCanada: 411 citing papers, 3.9% of this breakdownJapan: 378 citing papers, 3.6% of this breakdownAustralia: 372 citing papers, 3.5% of this breakdownSpain: 316 citing papers, 3% of this breakdownFrance: 306 citing papers, 2.9% of this breakdownNetherlands: 250 citing papers, 2.3% of this breakdownSwitzerland: 221 citing papers, 2.1% of this breakdown
0%27.9%Other 23.5%

Fields

  • Medicine49.9%
  • Neuroscience31.4%
  • Biochemistry, Genetics and Molecular Biology13.3%
  • Immunology and Microbiology2.3%
  • Computer Science0.6%
  • Nursing0.5%
  • Other2%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms11.4%
  • Parkinson's Disease Mechanisms and Treatments11.2%
  • Alzheimer's disease research and treatments7.2%
  • Nuclear Receptors and Signaling3.1%
  • Neurological disorders and treatments3%
  • Immune cells in cancer2.8%
  • Other61.3%

Coauthors

All papers

Open in search
  1. Microglia states and nomenclature: A field at its crossroads

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ukpong B. Eyo, Elena Galea, Sonia Garel, Florent Ginhoux, Christopher K. Glass, Özgün Gökçe, Diego Gómez‐Nicola, Berta González, Siamon Gordon, Manuel B. Graeber, Andrew D. Greenhalgh, Pierre Gressèns, Melanie Greter, David H. Gutmann, Christian Haass, Michael T. Heneka, Frank L. Heppner, Soyon Hong, David Hume, Steffen Jung, Helmut Kettenmann, Jonathan Kipnis, Ryuta Koyama, Greg Lemke, Marina A. Lynch, Ania K. Majewska, Marzia Malcangio, Tarja Malm, Renzo Mancuso, Takahiro Masuda, Michela Matteoli, Barry W. McColl, Véronique E. Miron, Anna V. Molofsky, Michelle Monje, Éva Mracskó, Agnès Nadjar, Jonas J. Neher, Urtė Neniškytė, Harald Neumann, Mami Noda, Bo Peng, Francesca Peri, V. Hugh Perry, Phillip G. Popovich, Clare Pridans, Josef Priller, Marco Prinz, Davide Ragozzino, Richard M. Ransohoff, Michael W. Salter, Anne Schaefer, Dorothy P. Schafer, Michal Schwartz, Mikael Simons, Cody J. Smith, Wolfgang J. Streit, Tuan Leng Tay, Li‐Huei Tsai, Alexei Verkhratsky, Rommy von Bernhardi, Hiroaki Wake, Valérie Wittamer, Susanne A. Wolf, Long‐Jun Wu, Tony Wyss‐Coray - Neuron 2022 cited by 1,880

  2. Microglia morphophysiological diversity and its implications for the CNS

    Authors: , , , , , , , , , - Frontiers in Immunology 2022 cited by 411

  3. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

    Authors: , , , , , , , , , - Nature Genetics 1998 cited by 3,885

  4. PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2010 cited by 864

  5. Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain Pathology 2008 cited by 479

  6. Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

    Authors: , , , , - Journal of Neuroinflammation 2005 cited by 432

  7. Microglia: biology and pathology

    Authors: , - Acta Neuropathologica 2009 cited by 719

  8. Role of microglia in CNS inflammation

    Authors: , , - FEBS Letters 2011 cited by 389

  9. The case described by Alois Alzheimer in 1911

    Authors: , - European Archives of Psychiatry and Clinical Neuroscience 1998 cited by 218

  10. The molecular profile of microglia under the influence of glioma

    Authors: , - Neuro-Oncology 2012 cited by 357

  11. Changing Face of Microglia

    Authors: - Science 2010 cited by 614

  12. Microglia in brain tumors

    Authors: , , - Glia 2002 cited by 388

  13. Synapses, Microglia, and Lipids in Alzheimer’s Disease

    Authors: , , , - Frontiers in Neuroscience 2022 cited by 36

  14. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 240

  15. Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline

    Authors: , , , , , , , , - Acta Neuropathologica Communications 2019 cited by 63

  16. Glutathione relates to neuropsychological functioning in mild cognitive impairment

    Authors: , , , , , , - Alzheimer s & Dementia 2013 cited by 130

  17. Nucleo-cytoplasmic transport of TDP-43 studied in real time: impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons

    Authors: , , , , , , , - Acta Neuropathologica 2018 cited by 96

  18. Cytokine Signalling at the Microglial Penta-Partite Synapse

    Authors: , , , - International Journal of Molecular Sciences 2021 cited by 33

  19. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring

    Authors: , , , , , - Brain Tumor Pathology 2019 cited by 42

  20. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging

    Authors: , , , - Neuropathology and Applied Neurobiology 2007 cited by 213

  21. Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Walter Schulz‐Schaeffer, Nathalie Streichenberger, Stephen B. Wharton, Hans A. Kretzschmar - Acta Neuropathologica 2009 cited by 192

  22. Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease

    Authors: , , , , , - Parkinsonism & Related Disorders 2008 cited by 144

  23. An Open-Source AI Framework for the Analysis of Single Cells in Whole-Slide Images with a Note on CD276 in Glioblastoma

    Authors: , , , , , , , , , , , , - Cancers 2022 cited by 13

  24. PathoGraph: An Attention-Based Graph Neural Network Capable of Prognostication Based on CD276 Labelling of Malignant Glioma Cells

    Authors: , , , , , - Cancers 2024 cited by 10